‡a
Author's Effects of Clinicopathological Characteristics on the Survival of Patients Treated with PD-1/PD-L1 Inhibitor Monotherapy or Combination Therapy for Advanced Cancer: A Systemic Review and Meta-Analysis
‡a
applicationandprospectofcdk46inhibitorsinmalignantsolidtumors
‡A
The application and prospect of CDK4/6 inhibitors in malignant solid tumors
‡9
1
‡a
effectsofclinicopathologicalcharacteristicsonthesurvivalofpatientstreatedwithpd1pdl1inhibitormonotherapyorcombinationtherapyforadvancedcancerasystemicreviewandmetaanalysis
‡A
Effects of Clinicopathological Characteristics on the Survival of Patients Treated with PD-1/PD-L1 Inhibitor Monotherapy or Combination Therapy for Advanced Cancer: A Systemic Review and Meta-Analysis
‡9
1
‡a
clinicaloutcomescomparisonof10yearsversus5yearsofadjuvantendocrinetherapyinpatientswithearlybreastcancer
‡A
Clinical outcomes comparison of 10 years versus 5 years of adjuvant endocrine therapy in patients with early breast cancer
‡9
1